CoChat

Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam

Greenblatt, David J., Divoll, Marcia, Harmatz, Jerold S., Shader, Richard I. · 1982 · Journal of Pharmaceutical Sciences

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Ten healthy volunteers received single 2-mg doses of lorazepam on five occasions in random sequence. Modes of administration were: A, intravenous injection; B, deltoid intramuscular injection; C, oral tablets in the fasting state; D, sublingual dosage of oral tablets in the fasting state; and E, sublingual dosage of specially formulated tablets in the fasting state. Kinetic variables were determined from multiple plasma lorazepam concentrations measured during 48 hr postdose. After intravenous lorazepam, mean (+/- SE) values were: elimination half-life (t 1/2 beta), 12.9 (+/- 0.8) hr; volume of distribution, 1.3 (+/- 0.07) liters/kg; total clearance, 1.21 (+/- 0.1) ml/min/kg. Absorption of intramuscular lorazepam was rapid. Peak plasma levels were reached at 1.15 hr after dosage, with absorption half-life averaging 14.2 (+/- 4.7) min. Absorption or oral and sublingual lorazepam tended to be less rapid than intramuscular injection, although differences were not significant. Times of peak concentration were 2.37, 2.35, and 2.25 hr postdose for trials C,D, and E, respectively; values of absorption half-life were 32.5, 28.5, and 28.7 min. Absolute systemic availability for trials B, C, D, and E averaged 95.9, 99.8, 94.1, and 98.2%, respectively; none of these differed significantly from 100%. Values of t1/2 beta were highly replicable within individuals regardless of the administration route. Thus, sublingual lorazepam is completely absorbed and is a suitable administration route in clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1002/jps.2600710227

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Research works printed but not linked: 2

  1. Greenblatt, 1980, J. Pharmacol. Exp. Ther., 215, 86
  2. Kraus, 1978, ibid., 24, 411

Cited by

See all 134

Metadata

Authors
Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I.
Affiliations
Tufts University (US)
Corresponding author
Greenblatt, David J.
Venue
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
1982-02
Volume
71
Issue
2
Pages
248-252
ISSN
0022-3549 (ISSN-L)
OpenAlex
W2143672875
Cited by
134
References
8
Citations by year
2026: 1 · 2024: 2 · 2023: 7 · 2022: 5 · 2021: 3 · 2019: 1 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 7 · 2012: 4
FWCI
3.56
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Pharmaceutical Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
lorazepam, sublingual administration, pharmacokinetics, route of administration, intramuscular injection, intravenous administration, oral tablets, absorption half-life, absolute bioavailability, elimination half-life, volume of distribution, drug clearance
MeSH terms
Administration, Oral, Adult, Female, Half-Life, Humans, Injections, Intramuscular, Injections, Intravenous, Kinetics, Lorazepam, Male, Mouth Floor, Anti-Anxiety Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam. https://app.cochat.ai/papers/10.1002/jps.2600710227
The paper
Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982). Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam. Journal of Pharmaceutical Sciences. https://doi.org/10.1002/jps.2600710227

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.